Koszelewski Dominik, Ostaszewski Ryszard, Śmigielski Paweł, Hrunyk Anastasiia, Kramkowski Karol, Laskowski Łukasz, Laskowska Magdalena, Lizut Rafał, Szymczak Mateusz, Michalski Jacek, Gawin Kamil, Kowalczyk Paweł
Institute of Organic Chemistry PAS, Kasprzaka 44/52, 01-224 Warsaw, Poland.
Department of Physical Chemistry, Medical University of Bialystok, Kilińskiego 1 Str., 15-089 Białystok, Poland.
Materials (Basel). 2021 Sep 18;14(18):5401. doi: 10.3390/ma14185401.
A preliminary study of 2-amino-4-aryl-3,5-dicarbonitrile-6-thiopyridines as new potential antimicrobial drugs was performed. Special emphasis was placed on the selection of the structure of target pyridine derivatives with the highest biological activity against different types of Gram-stained bacteria by lipopolysaccharide (LPS). Herein, model strains K12 (without LPS in its structure) and R2-R4 (with different lengths of LPS in its structure) were used. Studied target compounds were provided with yields ranging from 53% to 91% by the lipase-catalyzed one pot multicomponent reaction of various aromatic aldehydes with malononitrile, and thiols. The presented work showed that the antibacterial activity of the studied pyridines depends on their structure and affects the LPS of bacteria. Moreover, the influence of the pyridines on bacteria possessing smooth and rough LPS and oxidative damage to plasmid DNA caused by investigated compounds was indicated. Additionally, the modification of the bacterial DNA with the tested compounds was performed to detect new potential oxidative damages, which are recognized by the Fpg protein. The obtained damage modification values of the analyzed compounds were compared with the modifications after antibiotics were used in this type of research. The presented studies demonstrate that 2-amino-4-aryl-3,5-dicarbonitrile-6-thiopyridines can be used as substitutes for known antibiotics. The observed results are especially important in the case of the increasing resistance of bacteria to various drugs and antibiotics.
开展了一项关于2-氨基-4-芳基-3,5-二腈基-6-硫代吡啶作为新型潜在抗菌药物的初步研究。特别强调了通过脂多糖(LPS)选择对不同类型革兰氏染色细菌具有最高生物活性的目标吡啶衍生物的结构。在此,使用了模型菌株K12(其结构中无LPS)和R2-R4(其结构中有不同长度的LPS)。通过各种芳香醛与丙二腈和硫醇的脂肪酶催化一锅多组分反应,所研究的目标化合物的产率为53%至91%。目前的研究表明,所研究吡啶的抗菌活性取决于其结构,并影响细菌的LPS。此外,还指出了吡啶对具有光滑和粗糙LPS的细菌的影响以及所研究化合物对质粒DNA的氧化损伤。另外,用测试化合物对细菌DNA进行修饰以检测新的潜在氧化损伤,这些损伤可被Fpg蛋白识别。将分析化合物获得的损伤修饰值与在这类研究中使用抗生素后的修饰值进行比较。目前的研究表明,2-氨基-4-芳基-3,5-二腈基-6-硫代吡啶可作为已知抗生素的替代品。鉴于细菌对各种药物和抗生素的耐药性不断增加,所观察到的结果尤为重要。